With the adoption of new technologies and advancement of health care facilities, surgery of vital organs such as lungs has become easy. During this surgeries, anesthesia endotracheal tubes are used by surgeons to sedate the patient by delivering oxygen, xenon, and anesthetic agents such as sevoflurane & isoflurane. Thus, makes this market more attractive which enables the critical surgery more efficient. Additionally, it consider as a substitute for other drug delivery systems as they are also used to administer other medications such as salbutamol, ipratropium, and lidocaine.
Get Request Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2025
Different surgical procedures require administration of anesthesia through endotracheal tubes to manage treatment of various diseases such as gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. Therefore, increasing number of surgical procedures worldwide is projected to fuel growth of the anesthesia endotracheal tubes market over the forecast period. The significant growth in the number of surgeries, especially in the European countries will help in the growth of the anesthesia endotracheal tubes market in this region. For instance, the amount of laparoscopic colostomy surgeries tripled in Spain and doubled in Slovenia between 2008 and 2014. Furthermore, various surgeries performed in ambulatory surgical centers include hernia procedure, cervix and uterus removal, transurethral excision, lens and cataract, and hysterectomy, which is expected to fuel market growth.
Furthermore, increase in aging population who suffer from asthma, pulmonary disease and chronic obstructive pulmonary disease is expected to favor the anesthesia endotracheal tubes market. According to world ageing population reports in the U.S. between 2015 and 2030, the number of people in the world aged 60 years or over is projected to grow by 56 per cent, from 901 million to 1.4 billion, and by 2050, the global population of older persons is projected to more than double its size in 2015, reaching nearly 2.1 billion.
Nevertheless, lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas, product recalls and presence of few anesthetists and certified nurse per capita of population are likely to inhibit the growth of the anesthesia endotracheal tubes market.
For instance in January 2014, Medtronic’s product- NIM TriVantage electromyography (EMG) Endotracheal Tube got terminated form the market by FDA, due to cuff leakage in the intraoperative cuff deflation which then requires re-inflation or replacement of the deflated tube in order to ensure the continued ventilation of the patient.
CR Bard’s The AGENTO I.C. silver-coated endotracheal tube (ETT) is a scientifically proven, ventilator-associated pneumonia (VAP) preventive device for patients at risk of intubation for 24 hours or longer that minimizes user dependence.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2025
Key players operating in the anesthesia endotracheal tubes market include Medtronic Plc, General Electric Company, C. R. Bard, Inc., ConvaTec Group plc, Smith Medical, Inc., KindWell Medical Equipment Co.,Ltd, Royax, Fuji Systems Corp., Teleflex Incorporated., Neurovision Medical Products and Intersurgical GmbH